MLXIPL and obesity disorder: Collectively, these data support the hypothesis that hepatic HGFAC expression and circulating levels of HGFAC are regulated by ChREBP activity both in rodents and in humans, and hepatic HGFAC expression is increased in obesity and diabetes.